← Back to Search

Photobiomodulation

Valeda PBM treatment for Age-Related Macular Degeneration

N/A
Waitlist Available
Research Sponsored by LumiThera, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 months

Summary

This trial is testing whether a certain eye treatment can help people with a certain type of vision problem.

Eligible Conditions
  • Age-Related Macular Degeneration

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Best Corrected Visual Acuity
Secondary study objectives
Central Drusen Thickness
Central Drusen Volume
Other study objectives
Contrast Sensitivity
Geographic Atrophy
Low Luminance- Best Corrected Visual Acuity
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PBM TreatmentExperimental Treatment1 Intervention
The Valeda™ Light Delivery System
Group II: Sham TreatmentPlacebo Group1 Intervention
The Valeda™ Light Delivery System non-effective treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Valeda PBM treatment
2019
N/A
~50

Find a Location

Who is running the clinical trial?

LumiThera, Inc.Lead Sponsor
5 Previous Clinical Trials
664 Total Patients Enrolled
~16 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top